- 864-MY-RESET
- Inquiries@EXOPYR.com
As traditional symbols of success become increasingly accessible, a different form of status is emerging – one measured not only by what…
From Our FounderYou Have a Strategy for Your Financial Capital. What Is the Strategy for Your Biological Capital? By Dr. Justin Mandel, DOMFounder &…
From Our FounderBy Dr. Justin Mandel, DOMFounder & Clinical Architect, EXOPYR For years, I kept seeing the same pattern in clinical practice. Patients would…
Objective biomarkers replace symptom-based assumptions.
Inflammation is understood as a coordinated biological process.
Longitudinal testing confirms whether biology is actually changing.
Who Is Managing Your Biological Portfolio?
You have a strategy for managing your financial capital. Your biology deserves the same intentional oversight. Biological Portfolio Management™ is EXOPYR’s framework for measuring biological performance, following change over time, and understanding the trajectory of your most important portfolio.
Infection, stress, diet, toxin load, and excess visceral fat each contribute in distinct, measurable ways.
Joint ache, fatigue, rash, and digestive disruption are common presentations — and often the least specific.
One resolves in days and announces itself. The other persists quietly, with no clear starting point.
Clinicians connect symptom history, risk factors, and targeted panels into a single working diagnosis.
Each method surfaces a different kind of evidence; knowing when to rely on which is the harder skill.
Daily habits shape inflammatory load well before any symptom becomes noticeable.